Molecular and Human In Vivo Study of an Innovative Plant-Derived Multifunctional Peptide Signaling the Collagen and Elastin Pathways and Melanin Production
Chrono Control Penta is a novel plant derived multifunctional bioactive peptide, which offer a tailored targeted approach to skin health by addressing both pigmentation and aging. Chrono Control Penta inhibits tyrosinase with an IC50 value of 202.8 µM. Additionally, it significantly increased collagen (+87.53%) and elastin (+61.29%) production and secretion (+66.29% and +69.74%, respectively) and decreased the Matrix metalloproteinase-9 (MMP-9) and MMP-2 secretion in aged human dermal fibroblasts, vs. aging condition. At the clinical level, Chrono Control Penta was demonstrated to be already active after 2 weeks, promoting a 9.3% reduction in pigmentation after 6 weeks of use, showing its efficacy in promoting skin complexion. Furthermore, it exhibited significant moisturizing (13.05%), anti-wrinkle (11.55%), and purifying effects (12.45%), as well as firming effects (6.35%), after 6 weeks. The peptide was also well tolerated, with no adverse effects reported in clinical patch tests. This timely study presents novel research on a plant derived peptide, Chrono Control Penta, a significantly contribution to the burgeoning cosmetic peptide market. Our rigorous findings make it a new powerful ingredient, offering a comprehensive solution for skin health, and establishing a strong foundation for future research and application.
Authors
- Lorenza d’Adduzio (ORCID: https://orcid.org/0000-0002-3356-0595)
- Carlotta Bollati (ORCID: https://orcid.org/0000-0002-5698-1325)
- Carmen Lammi (ORCID: https://orcid.org/0000-0002-7428-4486)
- Melissa Fanzaga (ORCID: https://orcid.org/0009-0002-3175-924X)
Institutions
- University of Milan (IT)
Publication Details
- Journal
- Cosmetics
- Published
- 2025-05-15
- DOI
- https://doi.org/10.3390/cosmetics12030100
- Citations
- 1
- Primary Topic
- Protein Hydrolysis and Bioactive Peptides
- Type
- article
- Field-Weighted Citation Impact
- 0.81